A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
Clinical trial NCT07282574 · RECRUITING
Trial details
- NCT number
- NCT07282574
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-10
- Primary completion
- 2028-05-30
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.